Biology:ExPEC10V
From HandWiki
ExPEC10V, also known as VAC-52416 or JNJ-69968054, is a vaccine against Escherichia coli infection.[1][2] It is an Escherichia coli polysaccharide conjugate vaccine.[1][2] The vaccine is administered by intramuscular injection.[1] It is being developed by Janssen Pharmaceuticals.[1] As of April 2023, ExPEC10V is in phase 3 clinical trials.[1] It is under development towards approval in the United States, Europe, and Japan.[1] The vaccine is a 10-valent form of the earlier ExPEC4V.[2]
See also
References
- ↑ 1.0 1.1 1.2 1.3 1.4 1.5 "VAC 52416". 28 April 2023. https://adisinsight.springer.com/drugs/800053991.
- ↑ 2.0 2.1 2.2 "It's Time to Embrace Vaccination as We Enter the Postantibiotic Era of Recurrent Urinary Tract Infection Management". The Journal of Urology 211 (6): 797–799. June 2024. doi:10.1097/JU.0000000000003969. PMID 38704743.
 |  |
